SKI Market

A+| A| A-|

Indian Indices

Sensex

78,285.07 521.16
( 0.67%)

Global Indices

Nasdaq

53,071.47 150.40
(0.28%)

Dow Jones

7,557.54 53.30
(0.71%)

Hang Seng

69,576.15 -167.92
(-0.24%)

Nikkei 225

10,649.07 -29.96
(-0.28%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530313

INE285U01025

3.7455607

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

20.1

149.32

EPS(TTM)

Face Value()

Div & Yield %

1.57

Back

Anka India reports standalone net loss of Rs 7.29 crore in the December 2025 quarter

Jan 24,2026

Net loss of Anka India reported to Rs 7.29 crore in the quarter ended December 2025 as against net profit of Rs 0.01 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

78,285.07 521.16 ( 0.67%)

53,071.47 150.40 (0.28%)

7,557.54 53.30 (0.71%)

69,576.15 -167.92 (-0.24%)

10,649.07 -29.96 (-0.28%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)